Thus, it was possible that FGF21 failed to exert its expected effects on glucose homeostasis and lipid oxidation, which led some researchers to hypothesize that obesity was an FGF21-resistant state [19]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.